Aldrosis Tablet
Marketer
Maverick Pharma Pvt Ltd
Salt Composition
Ibandronic Acid (150mg)
Overview Aldrosis Tablet
OsteoPro Tablet is indicated for the treatment and prevention of postmenopausal osteoporosis. It strengthens bones by inhibiting osteoclast activity, reducing bone breakdown and fracture risk in postmenopausal women with osteoporosis. OsteoPro Tablet is optimally administered on an empty stomach, consistently at evenly spaced intervals as directed by your physician. Consistent daily dosing enhances adherence. Continue treatment as prescribed, even if symptoms improve; full therapeutic benefit may take several days. OsteoPro Tablet complements a comprehensive treatment plan potentially including dietary modifications and calcium/vitamin supplementation. Common, typically mild and transient, side effects include headache, elevated cholesterol, dizziness, upper respiratory infection, urinary tract infection, musculoskeletal pain, dyspepsia, heartburn, and diarrhea. Persistent side effects warrant medical consultation. Serious adverse events, such as kidney impairment (especially with dehydration, diuretic use, or pre-existing kidney disease), hypocalcemia, and orofacial pain, require immediate medical attention. This medication is contraindicated during breastfeeding. Prior to initiation, disclose any kidney disease, hypocalcemia, or concurrent medications to your doctor, as interactions may occur, particularly with anti-infectives, antineoplastics, and other osteoporosis treatments. Regular monitoring of kidney function and mineral levels may be necessary. Smoking cessation is strongly advised as smoking diminishes bone mineral density, increasing fracture risk. Excessive alcohol consumption, which also contributes to bone loss, should be avoided.
Uses of Aldrosis Tablet
Managing and mitigating postmenopausal osteoporosis
Major Benefits of Aldrosis Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Aldrosis Tablet on an empty stomach.
Common Side effects of Aldrosis Tablet:
- Headache
- Musculoskeletal (bone, muscle or joint) pain
- Heartburn
- Diarrhea
- Indigestion
- Dizziness
- Hypercholesterolemia (high cholesterol)
- Upper respiratory tract infection
- Urinary tract infection
How to use Aldrosis Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Aldrosis Tablets. Ingest each tablet whole; do not crush, chew, or divide it. Administer Aldrosis Tablets on an empty stomach.
How Aldrosis Tablet works:
Aldrosis tablets contain a bisphosphonate, inhibiting osteoclast activity to reduce bone breakdown. This strengthens bone structure and lowers fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Aldrosis Tablet with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Aldrosis Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Aldrosis Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Aldrosis Tablet.
KidneySAFE IF PRESCRIBED
Aldrosis Tablet poses no safety concerns for patients with kidney disease and requires no dosage alteration. Nevertheless, its use is contraindicated in individuals experiencing severe renal dysfunction.
LiverSAFE IF PRESCRIBED
The use of Aldrosis Tablets in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
What if you forget to take Aldrosis Tablet :
Omit any missed Aldrosis Tablet dose; resume your usual regimen. Avoid taking a double dose.
Facts to Know About Aldrosis Tablet
| Label | Value |
|---|---|
| Chemical Category | Bisphosphonate analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Behavior Class | Bisphosphonates: Bone Resorption Inhibitors |


